Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (51-60 of 270) with videos related to

Pageof 27
Sort By:
Biomarker Research|February 19, 2021
Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemiaSatoshi Nishiwaki, Isamu Sugiura, Daisuke Koyama, et al.
Genes, Chromosomes & Cancer|January 19, 2006
Genomewide array-based comparative genomic hybridization analysis of acute promyelocytic leukemiaSivasundaram Karnan, Shinobu Tsuzuki, Hitoshi Kiyoi, et al.
Biochemical and Biophysical Research Communications|September 23, 2009
Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylationTakumi Sugimoto, Akihiro Tomita, Junji Hiraga, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH geneKaneyuki Ohbayashi, Masafumi Taniwaki, Manabu Ninomiya, et al.
International Journal of Hematology|May 13, 2008
Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature reviewMakoto Murata, Yuichi Ishikawa, Haruhiko Ohashi, et al.
Nagoya Journal of Medical Science|July 4, 2024
Clonal evolution process from essential thrombocythemia to acute myeloid leukemia in the original patient from whom the <i>CALR</i>-mutated Marimo cell line was establishedYoko Ushijima, Yuichi Ishikawa, Takahiro Nishiyama, et al.
Cytotherapy|January 13, 2026
Impact of CD5 expression on outcomes for chimeric antigen receptor-T cell therapy in relapsed and refractory diffuse large B-cell lymphomaTakuya Kawaguchi, Kazuyuki Shimada, Katsuya Furukawa, et al.
International Journal of Hematology|August 7, 2007
Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapyAkihiro Tomita, Junji Hiraga, Hitoshi Kiyoi, et al.
European Journal of Haematology|May 30, 2007
LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22)Shizuka Imagama, Akihiro Abe, Momoko Suzuki, et al.
European Journal of Haematology|April 9, 2005
Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experienceMasamitsu Yanada, Momoko Suzuki, Kohei Kawashima, et al.
Pageof 27

Showing results (51-60 of 270) with videos related to

Sort By:
Pageof 27
Biomarker Research|February 19, 2021
Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemiaSatoshi Nishiwaki, Isamu Sugiura, Daisuke Koyama, et al.
Genes, Chromosomes & Cancer|January 19, 2006
Genomewide array-based comparative genomic hybridization analysis of acute promyelocytic leukemiaSivasundaram Karnan, Shinobu Tsuzuki, Hitoshi Kiyoi, et al.
Biochemical and Biophysical Research Communications|September 23, 2009
Escape mechanisms from antibody therapy to lymphoma cells: downregulation of CD20 mRNA by recruitment of the HDAC complex and not by DNA methylationTakumi Sugimoto, Akihiro Tomita, Junji Hiraga, et al.
Cancer Genetics and Cytogenetics|June 18, 2003
A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH geneKaneyuki Ohbayashi, Masafumi Taniwaki, Manabu Ninomiya, et al.
International Journal of Hematology|May 13, 2008
Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature reviewMakoto Murata, Yuichi Ishikawa, Haruhiko Ohashi, et al.
Nagoya Journal of Medical Science|July 4, 2024
Clonal evolution process from essential thrombocythemia to acute myeloid leukemia in the original patient from whom the <i>CALR</i>-mutated Marimo cell line was establishedYoko Ushijima, Yuichi Ishikawa, Takahiro Nishiyama, et al.
Cytotherapy|January 13, 2026
Impact of CD5 expression on outcomes for chimeric antigen receptor-T cell therapy in relapsed and refractory diffuse large B-cell lymphomaTakuya Kawaguchi, Kazuyuki Shimada, Katsuya Furukawa, et al.
International Journal of Hematology|August 7, 2007
Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapyAkihiro Tomita, Junji Hiraga, Hitoshi Kiyoi, et al.
European Journal of Haematology|May 30, 2007
LRP16 is fused to RUNX1 in monocytic leukemia cell line with t(11;21)(q13;q22)Shizuka Imagama, Akihiro Abe, Momoko Suzuki, et al.
European Journal of Haematology|April 9, 2005
Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experienceMasamitsu Yanada, Momoko Suzuki, Kohei Kawashima, et al.
Pageof 27